Challenges for standardization of Clostridium difficile typing methods by Huber, Charlotte A. et al.
Challenges for Standardization of Clostridium difficile Typing
Methods
Charlotte A. Huber,a Niki F. Foster,b Thomas V. Riley,b David L. Patersona
The University of Queensland, UQ Centre for Clinical Research, Queensland, Royal Brisbane and Women’s Hospital Campus, Brisbane, Australiaa; University of Western
Australia, School of Pathology and Laboratory Medicine, Crawley, Western Australia, Australiab
Typing of Clostridium difficile facilitates understanding of the epidemiology of the infection. Some evaluations have shown that
certain strain types (for example, ribotype 027) are more virulent than others and are associated with worse clinical outcomes.
Although restriction endonuclease analysis (REA) and pulsed-field gel electrophoresis have been widely used in the past, PCR
ribotyping is the current method of choice for typing of C. difficile. However, global standardization of ribotyping results is ur-
gently needed. Whole-genome sequencing of C. difficile has the potential to provide even greater epidemiologic information
than ribotyping.
Clostridium difficile, a Gram-positive spore-forming anaerobe,is the leading cause of infectious diarrhea in the industrialized
world. C. difficile is known to express up to three toxins: toxin A
(TcdA), toxin B (TcdB), and, less commonly, a third toxin called
binary toxin (CDT). These toxins cause extensive colonic inflam-
mation, epithelial tissue damage, and cell death (1). C. difficile has
a highly dynamic genome which readily undergoes genetic ex-
change. Disease-causing C. difficile strains have arisen indepen-
dently from a common ancestor that dates back millions of years
(2–4).
The development of typing methods, in particular, ribotyp-
ing, has facilitated understanding of the epidemiology of C.
difficile since the late 1990s. Strains of C. difficile with appar-
ently increased virulence, especially ribotype 027, also known
as North American pulsed-field gel electrophoresis type 1
(NAP1) or restriction endonuclease analysis group BI, have
been described in the last 10 years. The increased virulence of
the NAP1/027/BI strain may be due to increased expression of
toxins A and B (5) as well as production of CDT, although this
remains controversial. This strain has emerged inmany regions
of the world and, although the evidence is somewhat inconsis-
tent, may be associated with increased severity, recurrence, and
significant mortality (1, 5–7).
In an extensive European study, PCR ribotype 027 was the
sixth most common ribotype, accounting for 5% of all toxi-
genic C. difficile isolates, with ribotype 014/020 being the most
prevalent (16%), followed by ribotype 001 (10%) and ribotype
078 (8%) (8). In the United States, the prevalence of ribotype
027 has been described to be as high as 14% in a recent study
(6). New ribotypes are frequently detected (1), including ri-
botypes 176, 198, and 244, which appear to have evolved from
the 027 lineage. These newly identified PCR ribotypes may
prove to be just as problematic as the ribotype 027 strain, high-
lighting the importance of methods to demonstrate strain re-
latedness. A recent study showed that isolates of ribotypes 176,
198, and 244 had erroneously been assigned to ribotype 027 by
restriction endonuclease analysis (REA) typing (9). Addition-
ally, earlier reports showed that not all NAP1 isolates are of
PCR ribotype 027 (10), emphasizing the need for a globally
standardized typing method for C. difficile (9, 10).
C. DIFFICILE TYPING METHODS APPLIED TODAY
Various typing methods for C. difficile are currently used: restric-
tion endonuclease analysis (REA), pulsed-field gel electrophoresis
(PFGE), multilocus sequence typing (MLST), repetitive-element
PCR typing, toxinotyping, and PCR ribotyping as well as multilo-
cus variable-number tandem-repeat analysis (MLVA). Serotyping
has been replaced by surface-layer protein A-encoding gene (slpA)
typing (11), and, with the recent advances in DNA sequencing
technology, whole-genome sequencing (WGS) (12) may be the
way of the not-too-distant future. Each of these methods is briefly
reviewed (Table 1).
RESTRICTION ENDONUCLEASE ANALYSIS
REA of C. difficile makes use of whole-genome DNA, which is
digested by the frequently cutting restriction enzymeHindIII. The
restriction fragments are resolved by agarose gel electrophoresis
(13). This technique was first used to track the spread ofC. difficile
in a hospital setting in 1986 (14). REA has high discriminatory
power and stability, but the method and interpretation are tech-
nically demanding and the data are difficult to exchange between
laboratories.
PULSED-FIELD GEL ELECTROPHORESIS
PFGE was one of the first molecular typing methods to be applied
to C. difficile, particularly in North America, where it has been
used for analysis of food-borne disease outbreaks caused by vari-
ous bacterial species for many years. It is still considered the stan-
dard in Canada and the United States and continues to be used
elsewhere for the investigation of epidemiologically related iso-
lates and in population studies. The technique resolves large frag-
ments of DNA generated from whole-genome macrorestriction
with an infrequently cutting restriction enzyme. For C. difficile,
this is usually SmaI (10), but SacII (15) and other restriction en-
zymes have also demonstrated good discriminatory power against
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C. difficile. Early use of this method was problematic due to diffi-
culty lysing spores and DNA degradation among some strains,
but, with the use of younger cultures and the addition of thiourea
to the electrophoresis buffer, 100% typeability can be achieved
(16). Problems remain in the speed of the method, with comple-
tion of analyses taking several days, in the requirement of special-
ist equipment for the PFGE technique (however, the equipment
can also be used for typing other microorganisms), and in inter-
pretation and exchange of data between laboratories. The latter
shortcoming could be improved through the provision of a stan-
dardizedmethodology, ladders, and software for interpretation as
well as an accessible database of “fingerprints” similar to the
CDC’s PulseNet program (www.cdc.gov/pulsenet).
MULTILOCUS SEQUENCE TYPING
MLST involves the partial amplification and sequencing of a se-
lection of housekeeping genes. The unambiguous sequence data
generated may easily be compared between laboratories. In 2010,
a MLST typing scheme with discriminatory power similar to that
of agarose gel-based PCR ribotyping was developed for C. difficile
(17) and is most useful for population studies. However, MLST is
relatively costly compared with PCR ribotyping (10, 18).
rep-PCR
Repetitive-element PCR (rep-PCR) typing is based on polymor-
phisms of repetitive elements that exist inmultiple copies in theC.
difficile genome. The DiversiLab system (bioMérieux, Marcy
l’Etoile, France) is a commercially available rep-PCR system that
has higher discriminatory power than agarose-based ribotyping in
typing C. difficile (19).
This high resolution may be useful for investigating outbreaks
within a hospital. Interlaboratory reproducibility has not yet been
assessed for the genotyping of C. difficile by the DiversiLab system
in an international setting (19).
TOXINOTYPING
C. difficile toxins A (TcdA) and B (TcdB) are encoded on a
well-defined chromosomal region of 19.6 kb called the patho-
genicity locus (PaLoc) (20). Toxinotyping is performed by PCR
amplification and subsequent restriction enzyme digestion of
10 regions of the PaLoc. Toxinotyping has very high reproduc-
ibility. Although the discriminatory power is not as good as it is
for PFGE and ribotyping, toxinotyping gives a good picture of
the toxigenic status of C. difficile strains (18), excluding binary
toxin.
TABLE 1 Summary table of C. difficile typing methods applied currently
Typing method Technique applied Benefit(s) Challenge(s)
Restriction endonuclease analysis
(REA)
Whole-genome restriction and detection
by agarose gel electrophoresis
High discriminatory power and stability Method is technically demanding;




Whole-genome restriction and detection
by pulsed-field gel electrophoresis
High discriminatory power The method is laborious; results
cannot easily be compared
between laboratories
Multilocus sequence typing (MLST) PCR amplification and sequencing of
parts of housekeeping genes
Stability and transferability of data Costs are high
Repetitive-element PCR typing
(Diversilab typing)
Repetitive-element PCR system High discriminatory power Interlaboratory reproducibility
needs to be assessed
Toxinotyping PCR amplification followed by
restriction enzyme digestion of 10
regions of the pathogenicity locus
Highly reproducible while giving a clear
view of the toxin status, excluding
binary toxin
Less resolution power than other
typing methods
PCR ribotyping PCR amplification of the 16S-23S
intergenic spacer region
Agarose-based PCR ribotyping PCR amplification followed by agarose
gel electrophoresis
A globally used reference library has
been established
Data are not easily
interchangeable between
laboratories
Sequencer-based PCR ribotyping PCR amplification followed by
sequencer-based capillary separation
Highly accurate, reproducible, and
interchangeable digital data are
obtained
No standardization of ribotype
nomenclature
Qiaxcel-based PCR ribotyping PCR amplification followed by Qiaxcel-
based capillary separation
Accurate and reproducible digital data
are obtained at low cost





Multiple singleplex PCR amplifications
followed by sequencer-based capillary
separation
Digital data with high resolution power
and the possibility to determine
phylogenetic relationships are
obtained
Relatively costly and labor-




PCR amplification of the variable region
of the slpA gene, followed by DNA
sequencing
Relevance to vaccine development Method is not widely used
Whole-genome sequencing Whole-genome sequencing by methods
such as Sanger, Roche 454, and
Illumina sequencing
Accurate and reproducible digital data
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PCR RIBOTYPING
PCR ribotyping, which is based on the amplification of the 16S-
23S intergenic spacer region (ISR) (21), is the preferred typing
method in Europe as well as Australia (15, 18, 22). PCR ribotyping
has also been recently employed in the United States (6).
Bacterial rRNA (rrn) operons are usually organized in the or-
der 16S rrnA-ISR-23S rrnA-ISR-5S rrnA, and their copy numbers
can range between 1 and 15. The published whole genome of C.
difficile strain 630 contains 11 rrn operons (2), but the number of
rrn operons is known to be subject to variation in C. difficile.
Compared with other bacterial species,C. difficile also has consid-
erable intraspecific diversity in the ISRs (22),making it suitable for
PCR ribotyping.
The concept of making use of the heterogeneity of the inter-
genic 16S-23S rRNA spacer regions in C. difficile was first de-
scribed in 1993 by Gürtler (23). In order to obtain smaller frag-
ments for improved analysis on agarose gels, newprimers closer to
the spacer region were designed by O’Neill et al. (21). This ap-
proach has since been routinely used by the Anaerobe Reference
Laboratory in Cardiff, United Kingdom, where a widely used li-
brary has been established (18).
SEQUENCER-BASED RIBOTYPING
A sequencer-based PCR ribotypingmethodmaking use of aWeb-
based database was developed in 2008, enabling data comparison
between laboratories. PCR amplification was performed using the
same primers as for agarose gel-based ribotyping except that one
of the primers was labeled with a fluorescent label. The amplicon
sizes were determined using an ABI genetic analyzer, and a data-
base was established (24). ThisWeb-based database allows adjust-
ment of different sequencer settings as well as of the main primer
pairs used. Known ribotypes can be determined by simply upload-
ing sequencer data files (http://webribo.ages.at/). Capillary se-
quencers are widely used in clinical laboratories (15, 24). How-
ever, standardization of the ribotype nomenclature remains a
challenge (25).
QIAXCEL-BASED RIBOTYPING
Recently, QIAxcel (Qiagen, Hilden, Germany) has become avail-
able as an alternative to agarose slab gel-based PCR ribotyping.
QIAxcel does not require the use of a fluorescein-labeled primer,
and the cost is around 3 to 4 dollars per isolate versus 6 to 7 dollars
if a DNA sequencer is used. However, although it is a vast im-
provement over agarose-based ribotyping (25), QIAxcel-based ri-
botyping has poorer resolution than sequencer-based ribotyping.
The limit of discrimination for QIAxcel is 3 to 5 bp for amplicons
in the range of 100 to 500 bp in length when separated with the
high-resolution cartridge, and for fragments between 500 bp and 1
kb, the resolution decreases to 50 bp. Also, in contrast to agarose-
and sequencer-based ribotyping, it is not possible to include an
internal ladder.
Therefore, normalization across capillaries may be inaccurate,
with the analysis instead relying on single alignment markers at
either end of the electrophoresis pattern.
MULTILOCUS VARIABLE-NUMBER TANDEM-REPEAT
ANALYSIS
MLVA involves using capillary electrophoresis, usually employing
a sequencer, to determine fragment sizes, and hence the number
of repeat sequences, at multiple PCR-amplified loci. The numbers
of repeats can differ between strains at each locus. MLVA has a
number of advantages over PCR ribotyping. The increased dis-
criminatory power of MLVA allows outbreaks to be tracked more
efficiently, and, in contrast to PCR ribotyping, it has the potential
to determine phylogenetic relationships. Several MLVA schemes
have been described for typing C. difficile. Recently, a MLVA
scheme was developed which could subtype clinically significant
ribotypes while still clustering isolates in concordance with PCR
ribotyping (26). However, 15 PCRs are required to be performed
for this MLVA scheme, making the approach relatively laborious
and expensive. Compared with traditional PCR ribotyping,
MLVAhas the additional advantage of producing digital data with
a decreased turnaround time.
These advantages may be due to the fact that, in contrast to the
use of slab-gel electrophoresis in traditional PCR ribotyping, cap-
illary electrophoresis is employed (26, 27).
SEROTYPING
Serotyping has traditionally been performed by slide agglutina-
tion or enzyme-linked immunosorbent assays, using specific an-
tisera. These methods allow the differentiation of 10 major sero-
groups (A, B, C, D, F, G,H, I, K, andX). Strains of the A serogroup
have a flagellar antigen in common that is responsible for cross-
agglutination on slides but can be divided into 20 subgroups by
polyacrylamide gel electrophoresis (11).
SURFACE-LAYER PROTEIN A-ENCODING GENE (slpA) TYPING
TheC. difficile cell surface contains the so called S-layer, consisting
of an immunodominant protein encoded by the slpA gene. slpA
typing was originally performed using PCR amplification of the
variable region of the slpA gene, followed by restriction fragment
length polymorphism (RFLP) analysis and DNA sequencing.
With the exception of serogroup A, the slpA nucleotide se-
quences were found to be 100% identical within a given serogroup
and different between serogroups. slpA typing may therefore re-
place serotyping (11). Some studies suggest a correlation between
ribotype and slpA type. However, a recently published study that
included a large number of genomes showed that isolates of the
same ribotype or MLST type may differ in slpA types. S-layer-
based typing may therefore have greater relevance to vaccine de-
velopment than conventional genotyping (12).
WHOLE-GENOME SEQUENCING (WGS)
The first C. difficile whole-genome sequence, published in 2006,
was generated by Sanger sequencing (2). In 2010, the evolutionary
dynamics of C. difficile were shown using Sanger sequencing in
combination with the next-generation sequencing technologies
Roche 454 and Illumina. Phylogenetic analyses were performed
on the 29 genome sequences generated (3). In two very recent
studies, 57 and 151 C. difficile genome sequences were generated
using Illumina sequencing, indicating that traditional genotyping
methods may not always provide sufficient information for epi-
demiological purposes (12, 28).
CONCLUSIONS
In order to study the C. difficile epidemiology, a typing method
with high discriminatory power and reproducibility is needed.
Among all the C. difficile typing methods applied globally, PCR
ribotyping has developed as the most widely used typing method.
PCR ribotyping is a straightforward and affordable typingmethod
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for C. difficile (25). However, although PCR ribotyping has been
commonly used since 1995, standardization remains difficult
(18, 25).
Ribotyping has traditionally been performed by agarose gel
analysis, which does not allow the assignment of a ribotype unless
the laboratory has the correct reference strains (15). Analysis of
band sizes is hampered due to poor resolution of agarose-gel elec-
trophoresis, and comparison of results between laboratories is un-
reliable.
Also, since the establishment of the globally used reference
library by the Anaerobe Reference Laboratory in Cardiff, United
Kingdom, PCR ribotyping has been further developed.
New primer pairs have been used, resulting in different am-
plicon lengths for the same PCR ribotype and posing additional
challenges to standardization of ribotyping nomenclature (25,
29, 30).
DNA sequencers are widely used and have very high accuracy
and resolution. Sequencer-based PCR ribotyping may therefore
be themethod of choice—however, there remains an urgent need
for standardization of ribotype nomenclature for global epidemi-
ology (24, 25). Toxinotyping and MLVA typing may be applied if
further resolution is needed in addition to ribotyping results (18,
27). Whole-genome sequencing may become the method of
choice for the investigation of C. difficile strains in the years to
come (12, 28).
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